We are live on
!
Find out more
VA
Verdad Advisers Portfolio holdings
AUM
$104M
This Fund
S&P 500
This Quarter
Est. Return
+13.25%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$88.8M
AUM Growth
+$1.45M
(+1.7%)
Cap. Flow
-$2.06M
Cap. Flow
% of AUM
-2.32%
Top 10 Holdings %
Top 10 Hldgs %
21.25%
Holding
237
New
133
Increased
18
Reduced
23
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Autohome
ATHM
|
+$2.49M |
| 2 |
BLTE
Belite Bio
BLTE
|
+$2.32M |
| 3 |
Revolution Medicines
RVMD
|
+$2.18M |
| 4 |
State Street
STT
|
+$2.13M |
| 5 |
Zymeworks
ZYME
|
+$1.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$4.03M |
| 2 |
TJX Companies
TJX
|
+$3.81M |
| 3 |
Johnson & Johnson
JNJ
|
+$2.79M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.66M |
| 5 |
Chevron
CVX
|
+$2.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 41.87% |
| 2 | Technology | 13.22% |
| 3 | Financials | 10.56% |
| 4 | Consumer Discretionary | 7.94% |
| 5 | Communication Services | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Foghorn Therapeutics
FHTX
$369M
| $117K | 0.13% |
+24,416
| New | +$134K |
|
152
Solid Biosciences
SLDB
$1.09B
| $107K | 0.12% |
+14,879
| New | +$95.6K |
|
153
iBio
IBIO
$69.5M
| $107K | 0.12% |
+56,318
| New | +$131K |
|
154
VistaGen Therapeutics
VTGN
$11.4M
| $106K | 0.12% |
+184,938
| New | +$112K |
|
|
YRD
155
Yiren Digital
YRD
$94.5M
| $96.8K | 0.11% |
56,303
+3,697
| +7% | +$13.1K |
|
156
PepGen
PEPG
$213M
| $96.3K | 0.11% |
+54,380
| New | +$306K |
|
157
SITE Centers
SITC
$156M
| $93.9K | 0.11% |
+17,387
| New | +$107K |
|
158
BGSF Inc
BGSF
$57.2M
| $93.3K | 0.11% |
+14,418
| New | +$84.2K |
|
159
AMC Global Media
AMCX
$509M
| $91.2K | 0.1% |
+13,429
| New | +$105K |
|
160
Acumen Pharmaceuticals
ABOS
$219M
| $88K | 0.1% |
+37,278
| New | +$95.1K |
|
161
Shattuck Labs
STTK
$768M
| $86K | 0.1% |
+13,378
| New | +$63.5K |
|
162
Designer Brands
DBI
$278M
| $80.6K | 0.09% |
+14,168
| New | +$95.3K |
|
163
Spero Therapeutics
SPRO
$70.5M
| $78.3K | 0.09% |
+33,455
| New | +$79.4K |
|
164
Under Armour
UAA
$2.18B
| $76.2K | 0.09% |
+12,889
| New | +$83.6K |
|
|
FINV
165
FinVolution Group
FINV
$949M
| $72.5K | 0.08% |
15,145
-12,837
| -46% | -$68.1K |
|
166
Riskified
RSKD
$808M
| $71.3K | 0.08% |
+18,182
| New | +$80.6K |
|
167
Jasper Therapeutics
JSPR
$23.3M
| $64.8K | 0.07% |
+73,967
| New | +$103K |
|
168
Verrica Pharmaceuticals
VRCA
$87.1M
| $64K | 0.07% |
+12,098
| New | +$77.5K |
|
169
Comtech Telecommunications
CMTL
$52.4M
| $63.4K | 0.07% |
+19,099
| New | +$98.2K |
|
170
Mammoth Energy Services
TUSK
$152M
| $55.7K | 0.06% |
+22,729
| New | +$51.7K |
|
|
DDL
171
Dingdong
DDL
$488M
| $54.4K | 0.06% |
+21,170
| New | +$58.8K |
|
172
Alector
ALEC
$267M
| $50.6K | 0.06% |
+23,554
| New | +$47.3K |
|
173
Ring Energy
REI
$383M
| $38.3K | 0.04% |
+25,058
| New | +$31.8K |
|
174
PLAYSTUDIOS Inc
MYPS
$60.4M
| $34.6K | 0.04% |
73,733
| – | – |
|
|
VIOT
175
Viomi Technology
VIOT
$54.1M
| $33K | 0.04% |
29,693
-23,079
| -44% | -$32.1K |
|
Similar funds
IAP
JRSI
SFG
TPW
ACM
TOTUOP
XFP
ICVCFVA
Verdad Advisers's Q1 2026 Portfolio in Review
As of Q1 2026, Verdad Advisers held 237 positions worth $88.8M, up 1.7% from $87.4M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Verdad Advisers's Q1 2026 filing shows 133 new, 18 increased, 23 reduced and 58 closed positions. Its largest new stake was Autohome: 121,317 shares worth $2.11M. The largest sale was Citigroup, an estimated $4.03M.
By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
- Verdad Advisers's largest Q1 2026 buy was Autohome: 121,317 shares worth $2.11M.
- Verdad Advisers added most to California Resources in Q1 2026, an estimated $867K increase.
- Verdad Advisers's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $2.79M.
- Verdad Advisers fully exited Citigroup in Q1 2026, selling an estimated $4.03M.
- Verdad Advisers's ten largest holdings make up 21% of its $88.8M portfolio in Q1 2026.
- Verdad Advisers opened 133 new positions and closed 58 in Q1 2026.
- Verdad Advisers's portfolio value rose 1.7% quarter-over-quarter to $88.8M.
Based on Verdad Advisers's 13F filing for Q1 2026, filed 15 May 2026.